Cost-effective but clinically inappropriate: new NICE intervention thresholds in osteoporosis (Technology Appraisal 464)

UK clinical guideline for the prevention and treatment of osteoporosis

(2017) J. Compston et al.   Archives of Osteoporosis

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research

(2016) Robert A Adler et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Clinical assessment and management of multimorbidity: summary of NICE guidance

(2016) Caroline Farmer et al.   BMJ-British Medical Journal

Clinical assessment and management of multimorbidity: summary of NICE guidance

(2016) Caroline Farmer et al.   BMJ-British Medical Journal

A systematic review of intervention thresholds based on FRAX

(2016) John A. Kanis et al.   Archives of Osteoporosis

FRAX-based assessment and intervention thresholds—an exploration of thresholds in women aged 50 years and older in the UK

(2015) E. McCloskey et al.   OSTEOPOROSIS INTERNATIONAL

Subtrochanteric fractures after long-term treatment with bisphosphonates: a European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report

(2010) R. Rizzoli et al.   OSTEOPOROSIS INTERNATIONAL

An evaluation of the NICE guidance for the prevention of osteoporotic fragility fractures in postmenopausal women

(2010) John A. Kanis et al.   Archives of Osteoporosis

Case finding for the management of osteoporosis with FRAX®—assessment and intervention thresholds for the UK

(2008) J. A. Kanis et al.   OSTEOPOROSIS INTERNATIONAL

The cost-effectiveness of alendronate in the management of osteoporosis

(2007) John A. Kanis et al.   BONE